Yahoo Finance
Novavax Chief Business Officer John Trizzino joins Yahoo Finance Live to discuss the company awaiting an FDA approval for its COVID vaccine, supply chain constraints, and the outlook for COVID-19.
Novavax Chief Business Officer John Trizzino joins Yahoo Finance Live to discuss the company awaiting an FDA approval for its COVID vaccine, supply chain constraints, and the outlook for COVID-19.